SAGE Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 53 U.S.-traded ETFs. SAGE has around 4.3M shares in the U.S. ETF market. The largest ETF holder of SAGE is the SPDR S&P Biotech ETF (XBI), with approximately 1.58M shares. Investors may also find of interest that the ETF with the largest allocation to SAGE stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 2.31%. On average, U.S. ETFs allocate 0.14% of SAGE to their portfolios.
Additionally, SAGE is a favorite stock for Vanilla and Value ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SAGE as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 46.99%.